Gavi pneumonia vaccine pledge wins qualified support from MSF

4 June 2020
lab_biotech_research_vaccine_big

One of the announcements made by Gavi, The Vaccine Alliance, around Thursday’s Global Vaccine Summit, has been around its donation to the Serum Institute of India.

Gavi will award $75 million of the remaining $262 million of the Advance Market Commitment (AMC) - a $1.5 billion fund that was launched in 2009 to pay for the introduction of the pneumonia vaccine in developing countries - to the Indian manufacturer.

The Serum Institute received quality approval for the pneumonia vaccine in December 2019, joining US drug giant Pfizer (NYSE: PFE) and UK-based GlaxoSmithKline (LSE: GSK), which already had their vaccines at the brink of market entry when the AMC was launched, and have received the bulk of the $1.5 billion subsidy pot, on top of the base price that they charge Gavi.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Company News Directory



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical